ArticleAmerican journal of respiratory cell and molecular biology2024
Getting the Timing Right: Controlling BCL-2 Inhibition as an Antifibrotic Therapy.
Joseph C Cooley et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it